EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer

Jasper P Hof, Lambertus A L M Kiemeney, Katja K H Aben, Antoine G van der Heijden, Alina Vrieling, Sita H Vermeulen

Clinical Genitourinary Cancer · 2026-02 · 24 (1) · 102464

DOI: 10.1016/j.clgc.2025.102464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genitourinary Cancer, 2026-02. Verfasst von Jasper P Hof und 5 weiteren Autor:innen. Beteiligte Einrichtung: IQ Health Science Department, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Medisch Spectrum Twente.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: Patients with NMIBC frequently experience recurrences. Yet, the timing and characteristics of subsequent recurrences are understudied. We aim to describe subsequent recurrences in a large, contemporary, population-based cohort. METHODS: We included 1915 patients from the UroLife study and the Nijmegen Bladder Cancer Study, diagnosed with primary NMIBC between 2011 and 2021. The conditional 1-, 3- and 5-year risks of first to fourth recurrence were calculated using Kaplan-Meier risks, stratified by clinicopathological factors. Patterns of subsequent tumors were described and visualized. RESULTS: We observed 671 first recurrences and 400 subsequent recurrences. The 3-year conditional recurrence risks for first, second and third recurrence were 31%, 45%, and 54%, respectively, and were similar for NMIBC risk groups. Recurrence after a low-, intermediate- or high-risk tumor (either primary or recurrent) was again of low-, intermediate- or high-risk in 74%, 62% and 44% of cases, respectively. Ten patients with low/intermediate-risk NMIBC and 89 patients with high-risk NMIBC progressed to MIBC or mBC. Seven out of these ten (70%) and 13 out of these 89 (15%) patients had a high-risk recurrence before progression. This study was limited to a patient cohort from The Netherlands. CONCLUSIONS: Our study provides reliable estimates of recurrence rates and patterns in NMIBC from a large, contemporary, population-based cohort. Recurring NMIBC tumors often exhibit similar clinicopathological characteristics, and patients with primary low- or intermediate-risk NMIBC that progresses to MIBC/mBC often have a high-risk recurrence before progression. These results can inform research into NMIBC recurrences and surveillance schedules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleAgedMiddle AgedAged, 80 and overCohort StudiesNeoplasm InvasivenessKaplan-Meier EstimateRisk FactorsDisease ProgressionNetherlandsNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

Observational studyOutcomeRecurring tumorsRisk stratificationUrothelial carcinoma

Autor:innen und Institutionen

  • IQ Health Science Department, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands; Department of Urology, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501D…
  • Department of Urology, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, PO Box 9101, 6500GB, Nijmegen, the Netherlands. Electronic address: sita.vermeulen@radboudumc.nl.

Förderung

  • KWF Kankerbestrijding
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Medisch Spectrum Twente

Zitieren

APA

Hof, J. P., Kiemeney, L. A. L. M., Aben, K. K. H., van der Heijden, A. G., Vrieling, A., & Vermeulen, S. H. (2026). Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer, 24(1), 102464. https://doi.org/10.1016/j.clgc.2025.102464

Vancouver

Hof JP, Kiemeney LALM, Aben KKH, van der Heijden AG, Vrieling A, Vermeulen SH. Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer. Clinical Genitourinary Cancer. 2026;24(1):102464. doi:10.1016/j.clgc.2025.102464

BibTeX
@article{Hof2026,
  author = {Hof, Jasper P and Kiemeney, Lambertus A L M and Aben, Katja K H and van der Heijden, Antoine G and Vrieling, Alina and Vermeulen, Sita H},
  title = {Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {102464},
  doi = {10.1016/j.clgc.2025.102464}
}
Kostenlos starten →